Current Products
It’s impossible to pursue every product opportunity in our markets of interest. Understanding the limits of time & focus, prevents the dilution of efforts & avoids the risk of under-investment, thereby aligning our focus on limited product verticals. We believe in specialization and have bundled people skills integrated to focus on selective product niches sticking to what we know best. We want our employees to be truly knowledgeable and that’s one of our key focus areas.
By focusing on limited product ranges, our ability to innovate products and extend effective customer services are efficiently attained.
Hapten has two product verticals, AllerDex to focus on Allergy & ImmuDex to focus on Immunoassays.
Products Under Development
We have strong research and manufacturing capabilities across our core businesses. Without it, we simply couldn't meet the continuous expectations of our customers and partners.
Hapten’s research team is actively engaged in the process of developing several interesting and innovative products in the domains of Allergy as well as Immunoassays. In fact, our product pipelines are full till 2025. Some of our innovative products are awaiting regulatory approvals and are expected to be launched by Q3, 2022. We strive to expand our efforts to realize a sustainable future for ourselves and our stakeholders.